#secombit - Twitter Hashtag

almost 3 years ago

#ESMO23 | @PAscierto: brain metastases and survival evaluation in the #SECOMBIT trial Here the whole interview 👉🏼 https://t.co/GFzRsjseaw

0

2

0

428

Oncology Brothers

@OncBrothers

almost 4 years ago

#Melanoma #ESMO22 Highlights w/ @DrSapnaPatel for the Community Oncologists. Practice Changing “these 3 studies are ready to go” - #SWOGS1801 - #IMMUNED - #SECOMBIT Full Int. - https://t.co/9fXBTz6a4d - https://t.co/ecZATiSQm0 #OncTwitter #MedTwitter @SWOG @DrChoueiri

4

27

9

2

0

Oncoinfo @Oncoinfo_it

almost 4 years ago

#ESMO22 | #SECOMBIT (sequential combo immuno and target therapy study): 4-years OS data and preliminary biomarkers evaluation @PAscierto @BernardAFox @OmidHamidMD @ProfGLongMIA @istitutotumori @myESMO #melsm #melanoma #Immunotherapy

0

9

3

0

Pawel Sobczuk @pawel_sobczuk

almost 5 years ago

#ESMO21 #melsm What is best sequence of therapy in #BRAF-mutaed #melanoma? Still no definitive answer after first OS results of #SECOMBIT trial 🌟BRAF+MEKi-->NIVO+IPI seems slightly inferior but no statistical significance @PAscierto @myESMO @OncoAlert

pawel_sobczuk's tweet photo. #ESMO21 #melsm
What is best sequence of therapy in #BRAF-mutaed #melanoma?
Still no definitive answer after first OS results of #SECOMBIT trial
🌟BRAF+MEKi-->NIVO+IPI seems slightly inferior but no statistical significance
@PAscierto @myESMO @OncoAlert https://t.co/sQc3VutL6G

0

27

10

2

0

Omid Hamid MD

@OmidHamidMD

almost 6 years ago

Total Progression Free Survival endpoint #ESMO20 #SECOMBIT interesting as induction arm mimics #IMspire150 with possible Tail of curve benefit @myESMO @PAscierto #melanoma

OmidHamidMD's tweet photo. Total Progression Free Survival endpoint #ESMO20 #SECOMBIT interesting as induction arm mimics #IMspire150 with possible Tail of curve benefit @myESMO @PAscierto #melanoma https://t.co/7CzW1SiLv4

0

9

1

0

Teresa Amaral, MD, PhD @TeresaSAmaral

almost 6 years ago

2 more takes on this topic (sequencing tx/ efficacy of 2L tx) in #melsm, while waiting for more mature data from the #SECOMBIT trial, that again show the importance of data from national registries @darioT_ @pawel_sobczuk @BeckiLee #ESMO20 @myESMO @OncoAlert

TeresaSAmaral's tweet photo. 2 more takes on this topic (sequencing tx/ efficacy of 2L tx) in #melsm, while waiting for more mature data from the #SECOMBIT trial, that again show the importance of data from national registries @darioT_ @pawel_sobczuk @BeckiLee
#ESMO20 @myESMO @OncoAlert https://t.co/VacTuU4rVK

Teresa Amaral, MD, PhD @TeresaSAmaral

almost 6 years ago

Tx sequencing IT-TT vs TT-IT in #BRAFV600mut melanoma- what should be given first? Data on approx. 300 pts showed that regardless of the sequence, pts progressed relatively rapidly w/ 1L&2L therapies w/ a similar risk of progression & mortality. #melsm #ESMO20 @myESMO

TeresaSAmaral's tweet photo. Tx sequencing IT-TT vs TT-IT in #BRAFV600mut melanoma- what should be given first? Data on approx. 300 pts showed that regardless of the sequence, pts progressed relatively rapidly w/ 1L&2L therapies w/ a similar risk of progression & mortality.
#melsm #ESMO20 @myESMO https://t.co/XtJyX6YQ6k

0

27

13

2

0

1

9

4

0

OncoAlert

@OncoAlert

almost 6 years ago

Day One #ESMO20 #OncoAlertTopTweeet 🚨 #BRAF mutated advanced #Melanoma and 1st line immune or BRAF-MEK inhibitors. #SECOMBIT trial Tweet @pawel_sobczuk

Pawel Sobczuk @pawel_sobczuk

almost 6 years ago

#BRAF mutated advanced #melanoma and 1st line treatment choice - Immunotherapy or BRAF-MEK inhibitors? awaited #SECOMBIT trial primary results show some trends towards "sandwich" scheme but we have to wait for more mature data #melsm @myESMO #ESMO20 @OncoAlert @TeresaSAmaral

pawel_sobczuk's tweet photo. #BRAF mutated advanced #melanoma and 1st line treatment choice - Immunotherapy or BRAF-MEK inhibitors? awaited #SECOMBIT trial primary results show some trends towards "sandwich" scheme but we have to wait for more mature data
#melsm @myESMO #ESMO20 @OncoAlert @TeresaSAmaral https://t.co/SM0vXRVkXL

0

12

6

1

0

1

3

1

0

Pawel Sobczuk @pawel_sobczuk

almost 6 years ago

#BRAF mutated advanced #melanoma and 1st line treatment choice - Immunotherapy or BRAF-MEK inhibitors? awaited #SECOMBIT trial primary results show some trends towards "sandwich" scheme but we have to wait for more mature data #melsm @myESMO #ESMO20 @OncoAlert @TeresaSAmaral

0

12

6

1

0

Top Tweets for #secombit

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users